The human ov-serpin monocyte neutrophil elastase inhibitor (MNEI) is encoded by a single gene SERPINB1. It is a highly efficient inhibitor of neutrophil granule proteases. Four murine genes with high sequence identity with MNEI were identified and fully sequenced, and these were named EIA, EIB, EIC, and EID. EIA, EIB and EIC showed the same seven-exon gene structure as SERPINB1. However, EIC included an additional, alternatively spliced, exon due to the insertion of an endogenous retrovirus-like sequence. EID lacked several exons and is a pseudogene. Reverse transcriptase-PCR showed that EIA, like MNEI, is expressed at high levels in many tissues. EIB is mainly expressed in brain, and EIC was only expressed as splicing variants unlikely to encode a functional serpin. Upon incubation with serine proteases, EIA formed inhibitory covalent complexes with pancreatic and neutrophil elastases, cathepsin G, proteinase-3, and chymotrypsin, as previously shown for MNEI, whereas EIB was only able to do so with cathepsin G. According to the new serpin nomenclature, the genes encoding EIA, EIB, EIC, and EID will be called Serpinb1, Serpinb1b, Serpinb1c, and Serpinb1-ps1. These data demonstrate that the four murine homologs of MNEI have met different evolutionary fates, and that EIA is the mouse ortholog of MNEI.
Serpins (serine protease inhibitors) are a superfamily of ϳ45-kDa proteins with a highly conserved tertiary structure. Serpins regulate important intracellular and extracellular proteolytic events, including apoptosis, complement activation, fibrinolysis, and blood coagulation (1, 2) .
Serpins inhibit proteases by a suicide substrate inhibition mechanism, whereby the protease reactive center interacts with a bait cleavage site between the P1 and P1Ј residues of the reactive center loop of the serpin (3). The two molecules form a 1:1 stoichiometric intermediate, which is stabilized into a covalent inhibitory complex. Fluorescence energy transfer experiments have shown that the stable inhibitory complex involves full insertion of the cleaved proximal reactive center loop (RCL) 1 of the serpin into ␤-sheet A of the molecule, which results in the pole to pole displacement of the protease (4, 5) . The recent, and long awaited, crystal structure of a covalent serpin-protease inhibitory complex has shed light on the mechanism of inhibition of serpins (6) . The full insertion of the RCL results in a hyperstable serpin molecule and leads to the distortion of the protease by pulling away the reactive serine from its catalytic partners. This mechanism of inhibition by distortion is dependent on the length of the RCL (6, 7) .
According to a recent phylogenetic analysis (8) , human serpins have been classified in nine clades. Clade B, also called ov-serpins (ovalbumin-related serpins), is the second largest clade in humans with 13 members identified so far. OV-serpins share a high degree of sequence identity and conserved exonintron patterns. They differ from other serpin clades by the lack of N-and C-terminal extensions, the lack of a cleavable hydrophobic signal sequence for secretion and the presence of other signature sequence motifs (9) . Recent studies of exonintron structures indicate that serpins are likely to have evolved by massive intron insertion and show that ov-serpins form an evolutionary distinct clade (10, 11) . Furthermore, in contrast to other serpin clades, ov-serpins lack signal sequences for secretion and are found in the cytoplasm (9) and, to a lesser extent, on the cell surface (12) and in the nucleus (13) . Human ov-serpin genes are clustered in two loci, 6p25 and 18q21, and fall into two subgroups based on the number of exons (14) . The eight-exon ov-serpins are only found on chromosome 18, whereas the seven-exon ov-serpins are found on both loci.
The seven-exon ov-serpin, human monocyte neutrophil elastase inhibitor (MNEI, SERPINB1), is one of the most efficient inhibitor of the neutrophil granule proteases, which include neutrophil elastase, proteinase-3 (PR3), and cathepsin G (CatG) (15) (16) (17) . These neutrophil granule proteases are directly responsible for the killing of phagocytosed pathogens (18) , but, conversely, an excessive release of neutrophil proteases in the extracellular milieu induces tissue damage (19) and impairs the clearance of apoptotic cells in chronic inflammatory diseases (20) . In an animal model of chronic lung inflammation, aerosolized recombinant human MNEI reduced the severity and the extent of the elastase-induced tissue damage (21) . The sustained activity of MNEI after instillation * This work was supported by the National Institutes of Health Grant HL66548-02 and a Pilot Grant from the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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EXPERIMENTAL PROCEDURES
cDNA Data Base Mining-Using human MNEI cDNA sequence, mouse dbEST data base was searched with BLAST (www.ncbi.nlm. nih.gov/BLAST/), and matches were further analyzed using DNAStar software for PC (DNAStar Inc., Madison, WI). Selected clones with high homology were obtained from the I.M.A.G.E. Consortium (22) and sequenced.
Southern Blot Analysis-Based on the cDNA sequence of EIA (AF426024) and the gene structure of MNEI (SERPINB1), two 32 Plabeled probes in the exon 7 coding region and 3Ј-untranslated region were generated as described previously (23) . Mouse genomic DNA was digested with restriction enzymes, separated on 0.8% agarose gels, and transferred onto nitrocellulose membranes. Membranes were hybridized, washed, and autoradiographed as described previously (23) .
Genomic DNA Sequencing and Analysis-A genomic lambda phage library from 129/SvJ mice, a generous gift from Dr. Michael Carroll (Center for Blood Research, Boston, MA), was screened with a 32 Plabeled EIA exon 7 probe. Lambda clone #1 containing EIA was digested with SacI, and lambda clone #3 containing EIB was digested with BamHI. Fragments were subcloned in pBluescript (Stratagene) and sequenced. The sequence data of EIA and EIB from these subclones were fragmentary, and mouse PAC clones from library RPCI21, constructed using female 129/SvevTACfBr mouse genomic spleen, were screened with EIA-and EIB-specific primers. PAC clone 507G8 was shown to contain EIA and two apparent paralogs, EIC and EID. PAC clone 672N8 contained EIB. Introns were cloned from PAC 507G8, using primers based on cDNA or genomic sequences from Celera TM or GenBank TM databases. All PCR fragments were amplified with Turbo Pfu polymerase (Stratagene), cloned in pSTBlue-1 or pT7Blue-2 (Novagen), and sequenced in both directions using an "oligonucleotide walk" strategy at the Molecular Biology Core Facilities of the Dana Farber Cancer Institute (Boston, MA). These PCR fragments were designed to overlap widely within exons to build the contig without ambiguity on the origin of the fragments.
RT-PCR and Rapid Amplification of cDNA Ends-Mouse brain, heart, liver, lung, spleen, testis total RNA, and bone marrow and pancreas mRNA were obtained from Clontech (Palo Alto, CA). Five micrograms of total RNA or 1 g of mRNA were reverse-transcribed in a 40-l reaction using Superscript II and oligo(dT) primers (Invitrogen, Carlsbad, CA). Identical control reactions were performed without reverse transcriptase to rule out genomic DNA contamination. mRNA expression levels of the "housekeeping" gene ␤-actin were also assayed using primers described previously (24) .
Specific primers for each of the four serpin cDNA were used with Platinum Taq DNA polymerase (Invitrogen) in 50-l PCR reactions for 30 and 35 cycles. The primer sequences and their positions are shown in Table I . Levels of expression were analyzed by densitometry on ethidium bromide-stained agarose gels. RACE reactions were performed as described previously (25), using 5Ј/3Ј-RACE kit (Roche Molecular Biochemicals) and heart total RNA (Clontech).
In Vitro Transcription/Translation-The complete cDNA coding sequences of EIA (AF426024) and EIB (AF426025) were subcloned into pET17b (Novagen). The proteins were synthesized by in vitro transcription and translation in the presence of [ 35 S]methionine for 2 h at 37°C using an Escherichia coli T7 S30 extract system for circular DNA (Promega).
Inhibitory Complex Formation with Proteinases-Human neutrophil elastase (hNE), and porcine pancreatic elastase (pPE) were from Elastin Products (Owensville, MO); cathepsin G (hCatG) and proteinase-3 (hPR3) from human neutrophils were from Athens Research and Technology (Athens, GA); bovine chymotrypsin (bChy) was from Sigma (St. Louis, MO). They were stored in 1 mg/ml aliquots at Ϫ20°C. Purified recombinant murine granzyme B (mGrzB) (26) was a generous gift from Dr. Judy Lieberman (Center for Blood Research, Boston, MA) and was kept in 0.5 mg/ml aliquots at Ϫ20°C.
The ability of recombinant EIA and EIB to form inhibitory complexes with proteases was assessed by incubating 2.5 l of the in vitro translation reaction with different concentrations of proteases in a final volume of 20 l phosphate-buffered saline (pH 7.4). All the reactions were prepared on ice and incubated for 5 min at 37°C. Where indicated, EIB was incubated with proteases for up to 30 min. Samples were chilled on ice and acetone-precipitated. Pellets were resuspended in 1ϫ NuPAGE LDS sample buffer (Invitrogen), boiled for 3 min, loaded onto 10% Bis-Tris NuPAGE gels, and separated under reducing conditions in MES buffer. 35 S-Labeled proteins were detected in dried gels by phosphorimaging (Storm 860 PhosphorImager, Molecular Dynamics, Sunnyvale, CA) and analyzed using the ImageQuant software (Molecular Dynamics).
RESULTS

Gene Structure of the Mouse Homologs of MNEI-
In preliminary screening of the dbEST data base, fourteen murine submissions with high homology to human MNEI (SERPINB1) were identified using a BLASTn search. Sequencing of selected clones revealed one full-length clone (I.M.A.G.E. Consortium CloneID 63727). The thirteen partial clones were 97-100% identical to the full-length clone, strongly indicating that all are products of the same gene, which was named EIA. However, Southern blot analysis of digested genomic DNA using two EIA probes in exon 7 coding and non-coding regions revealed three bands, indicating the presence of three or more homologous genes in the mouse genome (Fig. 1) .
Four genes with homology with SERPINB1 were fully sequenced as follows. Mouse genomic DNA lambda clones con- Mouse genomic DNA was digested with the indicated restriction enzymes and hybridized as indicated with an exon 7 coding region (CR) or a 3Ј untranslated region (3ЈUTR) probe. Both probes hybridized with three fragments generated by all restriction endonucleases. Note that one band generated with the 3Ј-UTR probe and EcoRI is a doublet. DNA size markers (kb) are shown on each side.
taining EIA and a homologous gene, EIB, were isolated after screening with a 32 P-labeled EIA exon 7 probe and sequencing PCR products with primers based on exon 7 sequence. The sequencing data obtained from SacI subclones of lambda clone #1 containing EIA and from BamHI subclones of lambda clone #3, containing EIB, provided the sequence from exon 5 to 7 and several kilobases of 3Ј-flanking region of both genes. Using a PAC DNA library and primers based on cDNA sequence of exons, the sequence for EIA and EIB introns were obtained from PAC clones 507G8 and 672N8, respectively. Amplification from exon 4 to 5 of EIA using low stringency conditions produced two additional fragments with a small difference in size. Sequencing identified these as fragments of two new genes, EIC and EID. EIC gene was fully sequenced from exon 1 to 7 from PAC 507G8 using primers based on cDNA sequences obtained from RT-PCR studies (see below). EID putative exons were identified by searching the Celera data base with exon sequences of the other mouse EI genes. EID was sequenced using primers designed on genomic DNA sequences of putative exons 2, 4, 5, and 6 from BLAST searches of the Celera data base using EIA and EIC exon sequences. The structure of human MNEI and the four murine homologs is shown in Fig. 2 .
The complete sequencing of the four identified mouse genes showed both conserved and different features compared with human MNEI gene, SERPINB1 (Fig. 2 ). EIA and EIB had a similar seven-exon structure with exon size and codon phasing identical to those of human MNEI. The introns sizes were also similar. EIC shared these features and only differed in that an unusually large (ϳ8.0kb) intron II was present, when compared with other ov-serpin genes. The sequence analysis of this intron revealed that this was due to the insertion of a murine endogenous retrovirus-like (MuERV-L) element of ϳ6.5 kb widely found in the murine genome (27, 28) . In RT-PCR analysis (see below), it appeared that this large intron includes an alternatively spliced exon 2b, which contains a premature stop codon.
Although EID contains structural similarities with MNEI, no putative exon 3 or exon 7 were found in the Celera data base nor in the sequenced PAC 507G8 fragment amplified from exon 2 to 4. Moreover, exons 2 and 5 contain several stop codons, and both exons induce a codon phase shift, because they are one base pair longer or shorter than the consensus, respectively. The base pair identity score of the overlapping cDNA coding sequences for the four murine genes is 85-89% when compared with each other and 74 -79% when compared with MNEI, with EIA being the closest to MNEI.
mRNA Expression in Tissues and EIC Splicing VariantsDue to the high level of sequence identity between the four mouse EI genes, the specificity of each reaction was confirmed in control PCRs with cloned cDNA templates of EIA, EIB, and EIC and cloned genomic template of EID. EIA mRNA was expressed in all tissues investigated, and the signals were comparable to those of ␤-actin, except in bone marrow, spleen, and pancreas, where EIA mRNA expression was higher than that of ␤-actin, and in heart and liver where a lower expression level was observed (Fig. 3A) . EIB signal was comparable to that of EIA in brain, but the signal was one to two orders of magnitude lower in lung, spleen, and testis, and no amplification was seen in the other tissues. Interestingly, EIC was only detectable in heart, but the product (ϳ830 bp) was smaller than expected (972 bp, from exon 2 to 7). EID could not be amplified from any tissue.
To characterize the EIC PCR product, a second round of PCR was performed with the same primer pair (exons 2 and 7). Four products were sequenced, and all arose from EIC by alternative splicing (Fig. 3B) . Two of these variants contained premature stop codons (indicated by asterisks in Fig. 3B ). The two other variants lacked the endogenous retrovirus exon 2b as well as 
Characterization of the Mouse Homologs of the ov-serpin MNEI
exons 4 and 5 or exon 5 and 64 bp of exon 6. If these messages are translated into proteins, they are unlikely to be functional serpins because they all lack exon 5, which encodes for strand 3 of ␤-sheet A, a critical structure for the correct insertion of the RCL.
A further degree of complexity into EIC structure was added with the sequencing results of 5Ј-RACE. Several fragments were cloned and sequenced after two rounds of PCR using nested primers specific for exon 3 of EIC. One product contained sequences of exons 1, 2, and 3 of EIC but not exon 2b. Interestingly, another product contained exon 3 of EIC preceded by 555 bp with high homology with another murine ov-serpin, R86, found in the same locus on chromosome 13 (29) . Analysis of the Celera genomic data base revealed a gene remnant that mapped ϳ40 kb upstream of EIC and consisted only of exons 1 and 2; it was named R86B. To rule out a cloning artifact during 5Ј-RACE, the expression of the R86B/EIC chimeric mRNA was re-examined by RT-PCR using a R86B-specific exon 2 forward primer together with the same reverse primer in exon 7 of EIC. The expression level and tissue pattern was identical to that of EIC (Fig. 3A) . Furthermore, the R86B/EIC band was also smaller than expected corresponding to a splicing product unlikely to produce a functional serpin.
Formation of Stable Proteinase-Inhibitor Complexes-The amino acid sequence and the length of the RCL are critical in defining the target range and the efficency of the inhibitory function of serpins. Fig. 4 shows an alignment of EIA, EIB, and EIC RCL with MNEI and other relevant human and murine serpins. EIA and MNEI show a strikingly conserved RCL length and sequence with identical putative P1 and P1Ј residues. It is predictable that MNEI and EIA share protease targets, whereas EIB would target a different range of enzymes. EIC, however, has two residues (Thr and Asp) in the hinge region, which are likely to interfere with a correct insertion of the RCL into ␤-sheet A. To verify their predicted function, EIA and EIB were produced in vitro with 35 S-label and allowed to form stable covalent complexes with several proteases (Fig. 5) . EIC and EID were not tested because no fulllength EIC cDNA could be identified and EID lacks exon 7, which contains the RCL. EIA formed SDS-stable complexes with human neutrophil elastase, porcine pancreatic elastase, human cathepsin G, bovine chymotrypsin, and human proteinase-3 but not with granzyme B (Fig. 5A) . When tested in par- FIG. 4 . Reactive center loop sequences suggest different protease targets for mouse homologs of MNEI. Amino acid sequences of reactive center loops of EIA, EIB, and EIC were aligned manually with those of human MNEI, proteinase inhibitor (PI)6, PI9, squamous cell carcinoma antigen 2 (SCCA2) and ␣1-antichymotrypsin (AACT). EIA and MNEI have almost identical sequences in this region underscoring possible similar protease targeting. Target proteases for human serpins are indicated on the right. Hydrophobic and apolar residues are indicated in yellow, acidic residues are in red, basic residues are in blue, and polar residues are in green. The asterisk indicates the position of the principal P1 residue for these serpins.
FIG. 3. Expression profiles of mouse EI genes.
A, tissue-specific mRNA expression of mouse EI genes. Mouse tissue RNA were amplified by RT-PCR using EIA-, EIB-, EIC-, and EID-specific primers. ␤-Actin was amplified as a ubiquitously expressed mRNA control. Note that EIA is expressed at high levels in all tissues, especially in bone marrow, spleen, and pancreas. EIB is mainly expressed in brain. EIC and the chimeric transcript R86B/EIC (see text) are only expressed in heart. Both products are smaller than those predicted by the gene organization (see text). EID was not detected in any tissues (not shown). B, splicing variants of EIC expressed in heart. The asterisks indicate the presence of premature stop codons. Note that all splicing variants lack exon 5 either alone or in combination with exon 4 or with 64 bp of exon 6, which contains an internal cryptic splice site. The first three variants also lack exon 2b, which is encoded in the MuERV-L sequence.
allel with the same proteases, EIB could only form a stable complex with cathepsin G but at a lesser efficiency than EIA (not shown). To make the case clearer, EIB was incubated for up to 30 min with hCatG or hNE, and the total amount of protein electrophoretically separated was doubled (Fig. 5B) .
DISCUSSION
The length and the sequence of the reactive center loop are critical for the inhibitory activity of serpins (6, 7) . MNEI and EIA share the same Cys-Met residues at position P1-P1Ј, and the lengths of the RCL are identical. Complex formation assays confirmed that EIA and MNEI share the same target proteases, because EIA formed stable complexes with the three neutrophil granule proteases, elastase, cathepsin G, and proteinase-3, and with pancreatic elastase and chymotrypsin. Furthermore, MNEI and EIA are both expressed in a wide range of tissues with the highest levels of expression in bone marrow, spleen, and pancreas. Interestingly, these tissues contain cells that constitutively produce large amounts of elastase and other target proteases, indicating that the presence of these serpins may protect against unwanted protease leakage, as previously proposed (14, 17) . The constitutive tissue expression of MNEI and EIA in many human and mouse tissues indicates that these molecules may also limit the tissue-damaging effects of neutrophil proteases in inflammatory processes. This view is supported by the protective effects of instilled recombinant human MNEI on elastase-induced pulmonary injury in rats (21) . This strongly supports the development of inhaled recombinant MNEI as a potential aerosol treatment for inflammatory lung diseases, including cystic fibrosis. However, although extracellular MNEI was shown to be a strong inhibitor of neutrophil elastase, the mechanism of release of MNEI from the cytosol to the extracellular milieu remains to be demonstrated and may involve an alternative secretion pathway, because ov-serpins lack signal peptide for secretion. Furthermore, PI-6, a closely related serpin, failed to be secreted from activated and unactivated platelets and various cultured cell lines (30) . It was also shown that overexpression and the addition of an N-terminal signal peptide did not result in secretion of the protein. Therefore, it is also possible that the ubiquitous expression of MNEI in humans and EIA in mouse is required for the inhibition of other proteases with a wider expression pattern than neutrophil proteases or pancreatic elastase. We recently showed that MNEI inhibits mast cell chymase, chymotrypsin, and prostate-specific antigen but not granzymes, trypsin-like serine proteases, or cysteine and metalloprotease family members (31) . The role of MNEI and EIA at inhibiting proteases with chymotrypsin-like specificity in vivo may provide further understanding of the conserved wide tissue range of expression in these species.
MNEI is the product of a single gene (SERPINB1), which is located on chromosome 6p25 (32) together with two other sevenexon ov-serpins, PI-6 (SERPINB6) and PI-9 (SERPINB9) (33) . In a recent mapping study, we have shown that the four murine MNEI homologs are located on chromosome 13 together with PI-6-and PI-9-related genes, in a region syntenic to human 6p25 (29) . The analysis of the mouse locus shows that it is likely that the common ancestor locus contained three genes corresponding to MNEI, PI-6, and PI-9, and that the murine gene repertoire expansion occurred after the two species diverged (29) . This hypothesis is supported by the presence of several pseudogenes and remnants in the mouse locus, whereas none have been identified in the human locus. If EIA is functionally similar to MNEI, what is the role of the three other paralogs? The gene and predicted protein structures of EIB indicate that it is a biologically active serpin. This was confirmed by its ability to form stable inhibitory complexes with cathepsin G, a protease with chymotrypsin-like specificity. However, EIB failed to inhibit elastase-like proteases, which was predicted by the great divergence of its RCL. Moreover, EIB is proteolytically degraded by elastases, proteinase-3, and chymotrypsin. EIB also differs from MNEI in that it has a lower level and restricted tissue range of mRNA expression. This demonstrates that EIB does not duplicate the activity of EIA.
The sequencing data show that EIC has the same gene structure as EIA and EIB with identical exon sizes and similar intron size, except that the insertion of a full-length MuERV-L element into what once was intron II has modified this region of the gene leading to the transcription of the alternatively spliced exon 2b (Figs. 2 and 3B ). The insertion of such sequences within genes has been shown to induce alternative splicing events involving the long terminal repeat (LTR) region of the endogenous retrovirus (34 -36) . In contrast, exon 2b of EIC corresponds to the antisense strand of the protease region of the pol gene. The pol gene, unlike the LTR, has no poly- Note that EIA forms inhibitory complexes with hNE, pPE, hCatG, bChy, and hPR3. In these conditions, EIB forms complexes with hCatG only and is proteolytically degraded by hNE, pPE, bChy, hPR3, but not mGrzB (not shown). B, 35 S-labeled EIB was incubated at 37°C for the indicated time with 200 ng of hCatG or hNE. Note that EIB forms stable complexes with hCatG, whereas it is degraded by increasing concentrations of hNE without formation of complex, indicating that EIB is a substrate for this protease. adenylation signal and therefore allows the transcription to carry on to the downstream exons of EIC. The mechanisms that produce the atypical splicing events involving exons 4, 5, and 6 of EIC as well as the intergenic variants of R86B/EIC are unclear because the exon/intron junctions are conserved. In any case, the cDNA sequences show that it is unlikely that any of the EIC splicing variants would translate into a biologically active serpin. Furthermore, the presence of polar and charged residues in the proximal hinge region of the RCL are unfavorable for serpin inhibitory activity. The second and fourth splicing variants described in Fig. 3B may produce proteins with yet unknown functions. Evolutionarily interesting splicing variants have been described in insect serpins where the exon containing the RCL is present in twelve alternative forms, which are mutually exclusive, offering a powerful way of expanding the target repertoire (37, 38) . Alternative splicing was also observed in human ov-serpins, squamous cell carcinoma antigen (SCCA) 1 and 2 (SERPINB3 and 4) and hurpin (SER-PINB13), but their biological relevance remains unclear (39, 40) . Similarly to EIC, mRNA splicing variants containing the first two exons of R86B and the downstream exons of EIC are unlikely to be functional serpins. However, the possibility that such chimeric proteins may be produced indicates that the repertoire of serpins may be even larger than that predicted by the number of genes.
EID lacks important features of an active serpin at the genomic level, and no mRNA transcript has been detected in any tissue: it is clearly a pseudogene. The absence of exon 7 in EID resolves the discrepancy between the Southern blot analysis and the number of genes, because the screening was done using exon 7 probes (Fig. 1) . Moreover, the restriction map of the fully sequenced mouse genes (not shown) is consistent with the size of the bands observed in Fig. 1 , indicating that it is unlikely that another gene with homology with MNEI and with a functional RCL (encoded in exon 7) is present in the mouse genome.
The four murine ov-serpins described here are homologous to human MNEI (SERPINB1) but have met different evolutionary fates. According to the new serpin nomenclature guidelines (2), the genes encoding EIA, EIB, and EIC will be called Serpinb1, Serpinb1b, and Serpinb1c, respectively. Because it is a pseudogene, EID will be called Serpinb1-ps1. Similarly, R86B is a pseudogene showing sequence homology with PI-9 and will therefore be called Serpinb9-ps2. We can conclude that, based on mRNA expression pattern and protease targets, EIA is the functional murine counterpart of MNEI and that, based on genomic mapping and sequence homology, it is likely that EIA is the mouse ortholog of MNEI. The phenotype of mice lacking EIA (Serpinb1) will provide interesting insight on the role of MNEI in regulating the activity of granule proteases against pathogens and in inflammatory diseases.
